January 2004
93
(1.53 g, 30%) as colorless prisms, mp 168—169 °C. 1H-NMR (300 MHz, plates, mp 186—187 °C. 1H-NMR (400 MHz, CD3OD) d: 2.2—2.3 (2H, m),
CD3OD) d: 3.45 (1H, dd, Jϭ9.9, 13.9 Hz), 3.78 (1H, dd, Jϭ3.3, 13.9 Hz), 3.26 (2H, t, Jϭ7.8 Hz), 3.54 (2H, t, Jϭ6.4 Hz), 4.87 (2H, s), 7.4—7.6 (5H,
3.84 (1H, dd, Jϭ8.3, 11.2 Hz), 3.99 (1H, dd, Jϭ4.6, 11.2 Hz), 4.33 (2H, s), m). IR (KBr) 2941, 2799, 1445, 1245, 745, 697 cmϪ1. FAB-MS calcd for
4.5—4.7 (1H, m), 7.4—7.6 (5H, m). IR (KBr) 2691, 2581, 1569, 1459,
1413, 1215, 939, 758, 704, 581 cmϪ1. FAB-MS calcd for C10H14NBr2
MW305.9493, found m/z 305.9509 [(Mϩ1)ϩ]. Anal. Calcd for
C10H15NBrCl: C, 34.97; H, 4.11; N, 4.08. Found: C, 34.76; H, 3.99; N, 4.01.
C10H15NBr MW 228.0388, found m/z 228.0387 [(Mϩ1)ϩ]. Anal. Calcd for
C10H15NBrCl: C, 45.39; H, 5.71; N, 5.29. Found: C, 45.78; H, 5.71; N, 5.37.
Preparation of N-Benzylazetidine (18) (Table 2, Entry 2) To a sus-
pension of N-benzyl-3-bromopropylamine hydrochloride (17) (396 mg,
Preparation of N-Benzyl-2-(bromomethyl)aziridine (13) and N-Benzy- 1.50 mmol) in THF (4.5 ml) was added n-BuLi (1.56 mol/l, n-hexane solu-
lallylamine (15) To a suspension of N-benzyl-2,3-dibromopropylamine tion, 1.92 ml, 3.0 mmol) at Ϫ78 °C under N2 atmosphere. After being stirred
hydrobromide (12) (343 mg, 1.0 mmol) in THF (3.0 ml) was added n-BuLi for 1 h at Ϫ78 °C, the reaction mixture was quenched with a phosphate
(1.56 mol/l, n-hexane solution, 1.28 ml, 2.0 mmol) at Ϫ78 °C under an N2 at- buffer solution (pHϭ6.0, 0.05 mol/l, 10 ml) and then extracted with AcOEt.
mosphere. After being stirred for 1 h at Ϫ78 °C, the reaction mixture was The AcOEt extract was washed with brine, dried over MgSO4, and evapo-
quenched with a phosphate buffer solution (pHϭ6.0, 0.05 mol/l, 10 ml) and rated in vacuo. The residue was purified by column chromatography (eluent
extracted with AcOEt. The AcOEt extract was washed with brine, dried over CHCl3–MeOH, 9/1) to give 18 (142 mg, 64%), and the free amine of 17
MgSO4, and evaporated in vacuo. The residue was purified by PTLC (eluent (46 mg, 14%) as each colorless oil.
CHCl3–MeOH, 9/1) to give the free amine of 12 (39 mg, 15%), 13 (72 mg,
39%), and 15 (20 mg, 19%).
18: Colorless oil, bp 70—75 °C/5 mmHg (lit.,13) bp 65—70 °C/4 mmHg).
1H-NMR (400 MHz, CDCl3) d: 2.06 (2H, quintet, Jϭ7.1 Hz), 3.20 (4H, t,
Free Amine of 12: Colorless oil. 1H-NMR (400 MHz, CDCl3) d: 1.82 Jϭ7.1 Hz), 3.55 (2H, s), 7.2—7.4 (5H, m). 13C-NMR (75 MHz, CDCl3) d:
(1H, br s), 3.02 (1H, dd, Jϭ6.8, 13.4 Hz), 3.20 (1H, dd, Jϭ3.4, 13.4 Hz), 17.7, 55.1, 63.9, 126.9, 128.3, 128.4, 138.3. IR (neat) 2957, 2818, 1493,
3.7—3.9 (4H, m), 4.2—4.4 (1H, m), 7.2—7.4 (5H, m). 13C-NMR (75 MHz, 1453, 1361, 1187, 733, 698 cmϪ1. EI-MS calcd for C10H14NBr MW
CDCl3) d: 34.2, 53.1, 53.3, 53.8, 127.7, 128.6, 129.0, 140.3. IR (neat) 3324,
3027, 2838, 1494, 1454, 1141, 738, 698, 570 cmϪ1. EI-MS calcd for
C10H13NBr2 MW304.9415, found m/z 304.9420 [Mϩ].
148.1126, found m/z 148.1108 [(Mϩ1)ϩ].
Free Amine of 17: Colorless oil.21) 1H-NMR (300 MHz, CDCl3) d: 2.07
(2H, m), 2.79 (2H, t, Jϭ6.9 Hz), 3.25 (1H, br s), 3.48 (2H t, Jϭ6.6 Hz) 3.81
(2H, s), 7.2—7.4 (5H, m).
13: Colorless oil.9) 1H-NMR (300 MHz, CDCl3) d: 1.54 (1H, d,
Jϭ5.9 Hz), 1.71 (1H, d, Jϭ3.3 Hz), 1.8—1.9 (1H, m), 3.20 (1H, dd, Jϭ6.3,
General Procedure for HPLC Analysis (Table 2, Entries 1, 3, 4)
Each reaction was carried out using a suspension of 17 (265 mg, 1.0 mmol)
10.2 Hz), 3.25 (1H, dd, Jϭ6.9, 10.2 Hz), 3.30 (1H, d, Jϭ13.2 Hz), 3.49 (1H,
1
d, Jϭ13.2 Hz), 7.1—7.3 (5H, m). The H-NMR data of 13 were identical to and n-BuLi (1.56 mol/l, n-hexane solution, 1.28 ml, 2.0 mmol) in THF (5 ml)
those of the known compound.9)
15: Colorless oil.10) 1H-NMR (300 MHz, CDCl3) d: 1.45 (1H, br s), 3.28 n-BuLi (1.56 mol/l, n-hexane solution, 1.28 ml, 2.0 mmol) was added to a
(2H, dt, Jϭ5.9, 1.3 Hz), 3.79 (2H, s), 5.1—5.2 (2H, m), 5.8—6.0 (1H, m), solution of 12-crown-4 (352 mg, 2.0 mmol) in THF (3 ml) at Ϫ78 °C, and
7.2—7.4 (5H, m). The 1H-NMR data of 15 were identical to those of the then the mixture was added to a suspension of 17 (265 mg, 1.0 mmol) in
known compound.10)
THF (2 ml). The whole mixture was stirred at Ϫ78 °C for 1 h. Each reaction
under the conditions shown in Table 2 (entries 1, 3). In the case of entry 4,
Preparation of N-Benzyl-3-bromoazetidine (14) To a solution of N- mixture was worked up in a similar manner to the case of preparative syn-
benzyl-3-hydroxyazetidine33) (163 mg, 1.0 mmol) and CBr4 (445 mg, thesis of 18. The corresponding resulting solution was analyzed by HPLC
1.34 mmol) in CH2Cl2 (1.0 ml) was added PPh3 (393 mg, 1.5 mmol) at 0 °C.
under the following conditions. Mobil phase: phosphate buffer (pHϭ6.0,
After being stirred for 0.5 h at 0 °C, the reaction mixture was evaporated in 0.05 mol/l)/MeCNϭ6/4, flow rate: 1.0 ml/min, column: Wakopack Fluofix
vacuo to give a residue. The residue was purified by column chromatogra- (4.6 mm f* 25 cm). The isolated compounds 18 (retention timeϭ10 min)
phy (eluent n-hexane–AcOEt, 2/8) to afford 14 (80 mg, 35%) as a colorless and 17 (retention timeϭ14 min) were used as the standard sample.
1
؉
oil. 1H-NMR (400 MHz, CDCl3) d: 3.3—3.4 (2H, m), 3.62 (2H, s), 3.7—3.9
H-NMR Analysis of the Intermolecular Br Li Coordination (Fig.
(2H, m), 4.3—4.5 (1H, m), 7.2—7.3 (5H, m). 13C-NMR (75 MHz, CDCl3) 4) (A) To THF-d8 (1.0 ml) were added n-hexane (0.21 ml) and n-dodecyl-
d: 34.3, 63.3, 64.6, 126.9, 128.0, 128.1, 137.1. IR (neat) 3027, 2953, 2832, bromide (0.081 ml, 0.34 mmol) at 0 °C. The mixture was stirred at room
…
1495, 1453, 1362, 1234, 1178, 758, 712, 696 cmϪ1. EI-MS calcd for temperature for 10 min, and the resulting solution was analyzed by 1H-NMR
C10H12NBr MW225.0153, found m/z 225.0143 [Mϩ].
(400 Mz) at 23 °C.
General Procedure for HPLC Analysis (Chart 3) To a suspension of
(B) To a solution of diisopropylamine (0.047 ml, 0.34 mmol) in THF-d8
12 (172 mg, 0.5 mmol) in THF (1.5 ml) was added n-BuLi (1.56 mol/l, n- (1.0 ml) was added n-BuLi (1.58 mol/l, n-hexane solution, 0.213 ml,
hexane solution, 0.64 ml, 1.0 mmol) under an N2 atmosphere at Ϫ78 °C and 0.34 mmol) at 0 °C. Then n-dodecylbromide (0.081 ml, 0.34 mmol) was
the mixture was stirred at Ϫ78 °C for 1 h. In the reaction of 13 or 14 with n- added to the mixture at 0 °C and stirred at room temperature for 10 min. The
BuLi, a solution of 13 (20 mg, 0.089 mmol) or 14 (20 mg, 0.089 mmol) in
THF (0.3 ml), and n-BuLi (1.56 mol/l, n-hexane solution, 0.057 ml,
resulting solution was analyzed by 1H-NMR (400 Mz) at 23 °C.
(C) To a solution of n-dodecylbromide (0.081 ml, 0.34 mmol) in THF-d8
0.089 mmol) was employed. The resulting reaction mixture was worked up (1.0 ml) was added n-BuLi (1.58 mol/l, n-hexane solution, 0.213 ml,
in a similar manner to the preparative syntheses of 13 and 15 to furnish the 0.34 mmol) at 0 °C. Then the mixture was stirred at room temperature for
crude reaction solution, which was subjected to HPLC analysis. Mobil 10 min, and the resulting solution was analyzed by 1H-NMR (400 Mz) at
phase: phosphate buffer (pHϭ6.0, 0.05 mol/l)/MeCNϭ6/4, flow rate:
2.0 ml/min, column: Wakopack Fluofix (4.6 mm f* 25 cm). The isolated
compounds 12 (retention timeϭ13 min), 13 (retention timeϭ8.5 min), 14
23 °C.
Acknowledgments This work was partially supported by Grants-in-Aid
(retention timeϭ10.5 min), and 15 (retention timeϭ4.5 min) were used as for Scientific Research on Priority Areas (A), (2) (No. 14044075) from the
each corresponding standard sample. Ministry of Education, Culture, Sports, Science and Technology, Japan and
N-Benzyl-3-bromopropylamine Hydrobromide (17) A suspension of by a grant for Scientific Research (B) (2) (No. 14370723) from the Japan
3-bromopropylamine hydrochloride (16) (3.29 g, 15 mmol), benzaldehyde Society for the Promotion of Science.
(1.59 g, 15 mmol), Et3N (2.09 ml, 15 mmol), and MgSO4 (1.8 g) in CH2Cl2
(60 ml) was refluxed under an N2 atmosphere for 1.5 h. The reaction mixture References and Notes
was filtered, and the filtrate was concentrated in vacuo. Then Et2O was
added to the residue and the precipitate was filtered off. The filtrate was
evaporated in vacuo to afford a crude imine product, of which the structure
1) Hayashi K., Sato C., Hiki S., Kumagai T., Tamai S., Abe T., Nagao Y.,
Tetrahedron Lett., 40, 3761—3764 (1999).
2) Hayashi K., Kumagai T., Nagao Y., Heterocycles, 53, 447—452
(2000).
3) Hayashi K., Hiki S., Kumagai T., Nagao Y., Heterocycles, 56, 433—
442 (2002).
4) Funke W., Chem. Ber., 102, 3148—3150 (1969).
5) Tomioka H., Sato K., Kajitani H., Akaki T., Shishido S., Antimicrob.
Agents Chemother., 44, 283—286 (2000).
1
1
was confirmed by H-NMR. H-NMR (300 MHz, CDCl3) d: 2.25 (2H, m),
3.49 (2H, t, Jϭ6.3 Hz), 3.74 (2H, t, Jϭ6.6 Hz), 7.3—7.5 (3H, m), 7.5—7.8
(2H, m), 8.32 (1H, s). The resulting crude imine was dissolved in MeOH
(25 ml) and cooled to 0 °C. After the addition of NaBH4 (567 mg, 15 mmol)
at 0 °C, the mixture was stirred at 0 °C for 0.5 h. Then the reaction mixture
was quenched with 3.5% HCl at 0 °C and concentrated in vacuo to remove
MeOH. The concentrated solution was washed with Et2O, adjusted to pH
8—9 with NaHCO3, and extracted with Et2O. The Et2O layer was extracted
with 3.5% HCl, and the water layer was evaporated in vacuo. The solid
residue was recrystallized from EtOH to afford 17 (3.14 g, 79%) as colorless
6) Gensler W. J., J. Am. Chem. Soc., 69, 1966—1968 (1947).
7) Barili P. L., Bellucci G., Ingrosso G., Marioni F., Morelli I., Tetrahe-
dron, 28, 4583—4589 (1972).
8) Galli C., Illuminati G., Mandolini L., Tamborra P., J. Am. Chem. Soc.,